Suscribirse

African Americans at Risk for Increased Iron Stores or Liver Disease - 21/08/11

Doi : 10.1016/j.amjmed.2006.05.049 
Fitzroy W. Dawkins, MD a, , Victor R. Gordeuk, MD a, Beverly M. Snively, PhD b, Laura Lovato, MS b, James C. Barton, MD c, Ronald T. Acton, PhD d, Gordon D. McLaren, MD e, Catherine Leiendecker-Foster, MS f, Christine E. McLaren, PhD g, Paul C. Adams, MD h, Mark Speechley, PhD h, Emily L. Harris, PhD i, Sharon Jackson, PhD b, Elizabeth J. Thomson, MS j
a Division of Hematology/Oncology, Department of Medicine, Howard University, Washington, DC 
b Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 
c Southern Iron Disorders Center, Birmingham, Ala 
d Departments of Microbiology, Medicine, and Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, Ala 
e Division of Hematology/Oncology, Department of Medicine, University of California, Irvine and Veterans Affairs Long Beach Healthcare System, Long Beach 
f Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 
g Epidemiology Division, Department of Medicine, University of California, Irvine 
h Department of Medicine, London Health Sciences Center, London, Ontario, Canada 
i Kaiser Permanente Center for Health Research, Portland, Ore 
j National Human Genome Research Institute, Bethesda, Md. 

Requests for reprints should be addressed to Fitzroy W. Dawkins, MD, Oncology, Ortho Biotech, 430 Route 22 East, Bridgewater, NJ 08807-0914.

Abstract

Purpose

We sought to determine the prevalence of elevated measures of iron status in African Americans and whether the combination of serum ferritin concentration >200 μg/L for women or >300 μg/L for men and transferrin saturation in the highest quartile represents increased likelihood of mutation of HFE, self-reported iron overload or self-reported liver disease.

Subjects and Methods

A cross-sectional observational study of 27,224 African Americans ≥25 years of age recruited in a primary care setting was conducted as part of the multi-center, multi-ethnic Hemochromatosis and Iron Overload Screening (HEIRS) Study. Measurements included serum ferritin concentration, transferrin saturation, testing for HFE C282Y and H63D, and self-reported iron overload and liver disease.

Results

Serum ferritin concentration >200 μg/L for women or >300 μg/L for men occurred in 5263 (19.3%) of African Americans, while serum ferritin concentration in this range with highest-quartile transferrin saturation (>29% women; >35% men) occurred in 1837 (6.7%). Adjusted odds of HFE mutation (1.76 women, 1.67 men), self-reported iron overload (1.97 women, 2.88 men), or self-reported liver disease (5.18 women, 3.73 men) were greater with elevated serum ferritin concentration and highest-quartile transferrin saturation than with nonelevated serum ferritin concentration (each P <.05).

Conclusions

Serum ferritin concentration >200 μg/L for women or >300 μg/L for men in combination with transferrin saturation >29% for women or >35% for men occurs in approximately 7% of adult African American primary care patients. Patients with this combination of iron test results should be evaluated for increased body iron stores or liver disease.

El texto completo de este artículo está disponible en PDF.

Keywords : African Americans, Serum ferritin, Transferrin saturation, HFE, Liver disease, Increased iron stores


Esquema


 The HEIRS Study was initiated and funded by NHLBI, in conjunction with NHGRI. The study is supported by contracts N01-HC-05185 (University of Minnesota), N01-HC-05186 (Howard University), N01-HC-05188 (University of Alabama at Birmingham), N01-HC-05189 (Kaiser Permanente Center for Health Research), N01-HC-05190 (University of California, Irvine), N01-HC-05191 (London Health Sciences Centre), and N01-HC-05192 (Wake Forest University). Additional support was provided by grant UH1-HL03679-07 from NHLBI and the Office of Minority Health, and by General Clinical Research Center (GCRC) grants to Howard University (M01-RR10284), University of California, Irvine (5M01RR 00827-29) and University of Alabama at Birmingham (M01-RR00032), sponsored by the National Center for Research Resources, National Institutes of Health (NCRR/NIH).


© 2007  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 120 - N° 8

P. 734.e1-734.e9 - août 2007 Regresar al número
Artículo precedente Artículo precedente
  • Lipoprotein (a) and Venous Thromboembolism in Adults: A Meta-Analysis
  • Francesco Sofi, Rossella Marcucci, Rosanna Abbate, Gian Franco Gensini, Domenico Prisco
| Artículo siguiente Artículo siguiente
  • Active Lipid Management In Coronary Artery Disease (ALMICAD) Study
  • Sanjaya Khanal, Omar Obeidat, Michael P. Hudson, Mouaz Al-Mallah, Mary Bloome, Mei Lu, Adam B. Greenbaum, Aaron D. Kugelmass, W. Douglas Weaver

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.